The invention relates to haloalkane dehalogenases and to polynucleotides encoding the haloalkane dehalogenases. In addition methods of designing new dehalogenases and method of use thereof are also provided. The dehalogenases have increased activity and stability at increased pH and temperature.
Claims What is claimed is: 1. An isolated, synthetic or recombinant polypeptide having a dehalogenase activity comprising: (a) an amino acid sequence having at least 97% sequence identity to SEQ ID NO: 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 44, 46, or 48; or (b) a fragment of (a) encoding a polypeptide having a dehalogenase activity. 2. The polypeptide of claim 1, wherein the polypeptide comprises an amino acid sequence that is at least 98% identical to SEQ ID NO: 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 44, 46, or 48. 3. The polypeptide of claim 1, wherein the polypeptide comprises an amino acid sequence that is at least 99% identical to SEQ ID NO: 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 44, 46, or 48. 4. The polypeptide of claim 1, comprising at least one amino acid modification selected from the group consisting of: D89G, F91S, T159L, G182Q, G182V, I220L, N238T, W251Y, P302A, P302L, P302K, P302R/S306R, and any combination thereof. 5. An isolated, synthetic, or recombinant nucleic acid comprising: (a) a nucleic acid sequence having at least 97% sequence identity to SEQ ID NO: 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 43, 45, or 47, wherein the nucleic acid encodes at least one polypeptide having a dehalogenase activity; or (b) a sequence fully complementary to (a); or (c) a nucleic acid encoding the polypeptide of claim 1. 6. A vector, a cloning vehicle, or a host cell comprising the nucleic acid of claim 5. 7. A method for producing a dehalogenase comprising (a) providing the nucleic acid of claim 5; and (b) expressing the nucleic acid to produce a dehalogenase, wherein optionally the nucleic acid is expressed in a host cell. 8. A method for producing (R)-(.+-.)-3-halo-1,2-propanediol comprising contacting a 1,3 dihalo-2-propanol with a polypeptide of claim 1 or a polypeptide encoded by a nucleic acid of claim 5, under conditions to produce (R)-(.+-.)-3-halo-1,2-propanediol. 9. A method for synthesizing glycerol, comprising contacting trichloropropane or dichloropropanol with a polypeptide of claim 1 or a polypeptide encoded by a nucleic acid of claim 5, under conditions to synthesise glycerol. 10. A method for producing an optically active halolactic acid, comprising contacting a dihalopropionic acid with a polypeptide of claim 1 or a polypeptide encoded by a nucleic acid of claim 5, under conditions to produce optically active halolactic acid. 11. A method for bioremediation, comprising contacting an environmental sample with a polypeptide of claim 1 or a polypeptide encoded by a nucleic acid of claim 5. 12. A method of removing a halogenated contaminant or halogenated impurity from a sample comprising contacting the sample with a polypeptide of claim 1 or a polypeptide encoded by a nucleic acid of claim 5. 13. A method for synthesizing a diol, comprising contacting a dihalopropane or monohalopropanol with a polypeptide of claim 1 or a polypeptide encoded by a nucleic acid of claim 5, under conditions to synthesise the diol. 14. A method for dehalogenating a halo-substituted cyclic hydrocarbyl, comprising contacting the halo-substituted cyclic hydrocarbyl with a polypeptide of claim 1 or a polypeptide encoded by a nucleic acid of claim 5, under conditions to dehalogenate the halo-substituted cyclic hydrocarbyl. 15. A polypeptide having a dehalogenase activity comprising: (a) an amino acid sequence as set forth in SEQ ID NO: 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 44, 46, or 48; or, (b) an amino acid sequence encoded by the nucleic acid sequence of SEQ ID NO: 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 43, 45, or 47. 